Stryker Corporation (NYSE:SYK) Shares Bought by Gouws Capital LLC

Gouws Capital LLC grew its position in shares of Stryker Corporation (NYSE:SYK) by 1.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,219 shares of the medical technology company’s stock after acquiring an additional 205 shares during the quarter. Stryker comprises 4.5% of Gouws Capital LLC’s portfolio, making the stock its 6th biggest position. Gouws Capital LLC’s holdings in Stryker were worth $7,527,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in SYK. Capital A Wealth Management LLC acquired a new stake in shares of Stryker in the fourth quarter valued at about $26,000. Goodman Advisory Group LLC acquired a new stake in shares of Stryker in the first quarter valued at about $32,000. City Holding Co. grew its stake in shares of Stryker by 528.6% in the first quarter. City Holding Co. now owns 88 shares of the medical technology company’s stock valued at $33,000 after buying an additional 74 shares in the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Stryker in the first quarter valued at about $40,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Stryker in the fourth quarter valued at about $42,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on SYK shares. JMP Securities reiterated a “market perform” rating on shares of Stryker in a research note on Monday, May 5th. BTIG Research reiterated a “buy” rating on shares of Stryker in a research note on Monday, July 14th. Needham & Company LLC increased their target price on Stryker from $442.00 to $448.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Sanford C. Bernstein set a $450.00 price target on Stryker in a report on Monday, May 5th. Finally, Citigroup reissued a “buy” rating and issued a $455.00 price target (up previously from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Four equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $430.10.

Insider Activity

In related news, Director Ronda E. Stryker sold 200,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the sale, the director owned 3,222,108 shares of the company’s stock, valued at approximately $1,212,962,556.60. This trade represents a 5.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 5.20% of the company’s stock.

Stryker Trading Up 0.4%

NYSE:SYK opened at $377.73 on Monday. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The business’s 50 day moving average is $387.17 and its two-hundred day moving average is $379.98. Stryker Corporation has a 52 week low of $322.03 and a 52 week high of $406.19. The company has a market cap of $144.41 billion, a PE ratio of 50.03, a P/E/G ratio of 2.74 and a beta of 0.91.

Stryker (NYSE:SYK) last released its earnings results on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, topping analysts’ consensus estimates of $3.07 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%. The company had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $5.92 billion. During the same quarter last year, the business posted $2.81 EPS. Stryker’s quarterly revenue was up 11.1% compared to the same quarter last year. On average, analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker’s dividend payout ratio (DPR) is 44.50%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.